125 related articles for article (PubMed ID: 32495866)
1. MiRNA-203a-5p alleviates the malignant progression of Wilms' tumor via targeting JAG1.
Bao JW; Li WJ; Guo JH; Lv ZB; Whang Z
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5329-5335. PubMed ID: 32495866
[TBL] [Abstract][Full Text] [Related]
2. [MiR-203a-5p Inhibits Multiple Myeloma Cell Proliferation and Cell Cycle Progression via Targeting
Zhang Y; Chen TT; Zhou HB; Chen WM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):801-809. PubMed ID: 37356943
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-539 inhibits the progression of Wilms' Tumor through downregulation of JAG1 and Notch1/3.
Su H; Wang X; Song J; Wang Y; Zhao Y; Meng J
Cancer Biomark; 2019; 24(1):125-133. PubMed ID: 30530967
[TBL] [Abstract][Full Text] [Related]
4. LncRNA PAPAS aggravates the progression of gastric cancer through regulating miRNA-188-5p.
Shi X; You X; Zeng WC; Deng YJ; Hong HL; Huang OX; Wang MF
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10761-10768. PubMed ID: 31858543
[TBL] [Abstract][Full Text] [Related]
5. LncRNA XIST promotes migration of Wilms' tumor cells through modulation of microRNA-193a-5p.
Yao FZ; He R; Jiang YC; Hou Y; Qian D
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9889-9898. PubMed ID: 33090392
[TBL] [Abstract][Full Text] [Related]
6. miR-140-5p could suppress tumor proliferation and progression by targeting TGFBRI/SMAD2/3 and IGF-1R/AKT signaling pathways in Wilms' tumor.
Liu Z; He F; OuYang S; Li Y; Ma F; Chang H; Cao D; Wu J
BMC Cancer; 2019 Apr; 19(1):405. PubMed ID: 31035970
[TBL] [Abstract][Full Text] [Related]
7. MiR-140-5p and miR-92a-3p suppress the cell proliferation, migration and invasion and promoted apoptosis in Wilms' tumor by targeting FRS2.
Li JL; Luo P
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):97-108. PubMed ID: 31957822
[TBL] [Abstract][Full Text] [Related]
8. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G
Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974
[TBL] [Abstract][Full Text] [Related]
9. LncRNA DLEU1 accelerates the malignant progression of clear cell renal cell carcinoma via regulating miRNA-194-5p.
He GZ; Yu SY; Zhou QP; Chen ML; Zhang YW; Zheng Y; Zhang ZB; Han ZY; Yu J
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10691-10698. PubMed ID: 31858537
[TBL] [Abstract][Full Text] [Related]
10. MiRNA-215-5p alleviates the metastasis of prostate cancer by targeting PGK1.
Chen JY; Xu LF; Hu HL; Wen YQ; Chen D; Liu WH
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):639-646. PubMed ID: 32017004
[TBL] [Abstract][Full Text] [Related]
11. miR-483-5p Targets MKNK1 to Suppress Wilms' Tumor Cell Proliferation and Apoptosis In Vitro and In Vivo.
Liu K; He B; Xu J; Li Y; Guo C; Cai Q; Wang S
Med Sci Monit; 2019 Feb; 25():1459-1468. PubMed ID: 30798328
[TBL] [Abstract][Full Text] [Related]
12. MiR-155-5p affects Wilms' tumor cell proliferation and apoptosis via targeting CREB1.
Zhao XS; Han B; Zhao JX; Tao N; Dong CY
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1030-1037. PubMed ID: 30779069
[TBL] [Abstract][Full Text] [Related]
13. Quantitative RT-PCR-based miRNA profiling of blastemal Wilms' tumors from formalin-fixed paraffin-embedded samples.
Buglyó G; Magyar Z; Romicsné Görbe É; Bánusz R; Csóka M; Micsik T; Berki Z; Varga P; Sápi Z; Nagy B
J Biotechnol; 2019 Jun; 298():11-15. PubMed ID: 30959135
[TBL] [Abstract][Full Text] [Related]
14. MiRNA-802 inhibits the metastasis of colorectal cancer by targeting FOXE1.
Zhang Y; Ma LN; Xie Y
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1778-1785. PubMed ID: 32141546
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma progression is protected by miRNA-34c-5p by regulating FAM83A.
Yu WS; Wang ZG; Guo RP; Lin ZQ; Ye ZW; Lu CL
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6046-6054. PubMed ID: 32572919
[TBL] [Abstract][Full Text] [Related]
16. MiRNA-188-5p alleviates the progression of osteosarcoma via target degrading CCNT2.
Wang F; Zhao QH; Liu JZ; Kong DL
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):29-35. PubMed ID: 31957815
[TBL] [Abstract][Full Text] [Related]
17. Circ-ABCB10 accelerates the malignant progression of oral squamous cell carcinoma by absorbing miRNA-145-5p.
Chen F; Li XH; Liu C; Zhang Y; Wang RJ
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):681-690. PubMed ID: 32016969
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA WT1-AS inhibits cell aggressiveness via miR-203a-5p/FOXN2 axis and is associated with prognosis in cervical cancer.
Dai SG; Guo LL; Xia X; Pan Y
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):486-495. PubMed ID: 30720155
[TBL] [Abstract][Full Text] [Related]
19. LncRNA CRNDE promotes the development of Wilms' tumor by regulating microRNA-424.
Cui WW; Sun YL; Chen C; Feng RR; Xu W; Meng JJ; Zhang K
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1088-1097. PubMed ID: 32096178
[TBL] [Abstract][Full Text] [Related]
20. LINC00339 accelerates invasion and migration of colorectal cancer via mediating miRNA-30a-5p.
Zhou P; Wu J; Zheng Z; Liao C; Sun X
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):226-231. PubMed ID: 38279428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
